Evidence map›Paper›PMID 30083151›Full record

ArticleFrontiers in microbiology2018

Eugénia Pinto, Carolina Monteiro, Marta Maia, Miguel A Faria, Virgínia Lopes, Catarina Lameiras, Dolores Pinheiro

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Genotype-Phenotype Relationships in Azole-ResistantJournal of fungi (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Article
  6. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Antifungal effect of soilIranian journal of microbiology · 2025
    Article
  11. Review
  12. Pathogenic Aspergillus spp. and Candida spp. in coastal waters from southern Brazil: an one health approach.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  13. Review
  14. Molecular Identification ofInfection and drug resistance · 2025
    Article
  15. Article
  16. Review
  17. Pan-azole- and multi-fungicide-resistantApplied and environmental microbiology · 2024
    Article
  18. Article
  19. Drug-ResistantPathogens (Basel, Switzerland) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eugénia PintoLaboratory of Microbiology, Biological Sciences Department, Faculty of Pharmacy of University of Porto, Porto, Portugal.
Carolina MonteiroLaboratory of Microbiology, Biological Sciences Department, Faculty of Pharmacy of University of Porto, Porto, Portugal.
Marta MaiaLaboratory of Microbiology, Biological Sciences Department, Faculty of Pharmacy of University of Porto, Porto, Portugal.
Miguel A FariaLAQV-REQUIMTE, Laboratory of Bromatology and Hydrology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Virgínia LopesMicrobiology Laboratory, Pathology Department, Centro Hospitalar do Porto, Porto, Portugal.
Catarina LameirasMicrobiology Service, Laboratorial Diagnostic Department, Instituto Português Oncologia do Porto Francisco Gentil, EPE (IPOFG-Porto), Porto, Portugal.
Dolores PinheiroLaboratory of Microbiology, Service of Clinical Pathology, Centro Hospitalar S. João EPE, Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal susceptibilityAspergillus spp.azole-resistant A. fumigatuscryptic speciescyp51A genemolecular identification

Identifiers

PMID30083151
PMCPMC6065200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.